Sherbrooke Park Advisers’s Aveanna Healthcare AVAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-17,647
Closed -$157K 213
2025
Q3
$157K Sell
17,647
-25,655
-59% -$162K 0.07% 410
2025
Q2
$226K Buy
43,302
+18,626
+75% +$94.7K 0.1% 367
2025
Q1
$134K Sell
24,676
-9,343
-27% -$44.1K 0.06% 479
2024
Q4
$155K Buy
34,019
+23,683
+229% +$121K 0.05% 624
2024
Q3
$53.7K Buy
+10,336
New +$46.7K 0.01% 863

Other funds holding AVAH

Sherbrooke Park Advisers's AVAH Position: Q4 2025 in Review

Sherbrooke Park Advisers sold out of Aveanna Healthcare (AVAH) in Q4 2025, closing a stake of 17,647 shares — an estimated $157K sold.

Sherbrooke Park Advisers first reported a position in AVAH in Q3 2024 and held it in 5 quarters. The position peaked at $226K in Q2 2025. 193 funds tracked by Wall St. Rank hold AVAH as of Q4 2025.

  • Sherbrooke Park Advisers reported no remaining Aveanna Healthcare position as of Q4 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 17,647 Aveanna Healthcare shares in Q4 2025, an estimated $157K.
  • Sherbrooke Park Advisers first reported a position in Aveanna Healthcare in Q3 2024 and held it in 5 quarters.
  • Sherbrooke Park Advisers's Aveanna Healthcare position peaked at $226K in Q2 2025.
  • 193 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q4 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.